Allarity Therapeutics, Inc. Accounts Payable
Allarity Therapeutics, Inc. (ALLR) had Accounts Payable of $4.11 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $4.11M.
- 2026-03-31: Accounts Payable, Current $4.24M.
- 2025-12-31: Accounts Payable, Current $4.28M.
- 2025-09-30: Accounts Payable, Current $4.60M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $4.11M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $4.24M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $4.28M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $4.60M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $4.61M 10-Q · filed 2025-08-15 | |
| 2025-03-31 | $4.35M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $4.18M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $4.69M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $7.75M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $11.06M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $8.42M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $6.35M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $8.09M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $6.45M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $6.25M 10-K · filed 2024-03-08 | |
| 2022-09-30 | $5.00M 10-K · filed 2023-03-13 | $4.71M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $5.55M 10-Q · filed 2022-10-07 | |
| 2022-03-31 | $5.80M 10-Q · filed 2022-05-27 | |
| 2021-12-31 | $698.00K 10-K · filed 2023-03-13 | |
| 2021-09-30 | $739.00K 10-Q/A · filed 2022-05-17 | |
| 2020-12-31 | $2.12M 10-Q/A · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |